Sunday, April 5, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

A conversation with Miss Tara Haelle, a health journalist and subject matter expert on vaccines

We discuss Miss Haelle’s struggles to overcome vaccine misinformation during the pandemic. As a journalist, she often found herself at odds with physicians despite her extensive track record of health journalism and research on vaccines.

Miss Haelle is a science and multimedia journalist who specializes in reporting on vaccines and other matters of public health, pediatric and maternal health, and mental health, among other topics. Her work has appeared in The New York Times, NPR, Scientific American, Medscape, and the Washington Post, just to name a few outlets. If you want to learn more about her writings and her journey as a writer, please visit her personal website.

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply

Your email address will not be published. Required fields are marked *

Videos

Policy Shift in Peptide Regulation

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!